<ul><li>Johnson & Johnson's Ottava surgical robot has received investigational device exemption (IDE) from the FDA.</li><li>The exemption allows Johnson & Johnson MedTech to begin a clinical trial for Ottava at U.S. sites.</li><li>Ottava features a unique architecture with four robotic arms and offers versatility in meeting patient and surgeon needs.</li><li>The robotic platform incorporates J&J's digital ecosystem and is designed for robotic, laparoscopic, hybrid, and open surgery.</li></ul>

Johnson & Johnson wins FDA exemption for Ottava surgical robot

Discover more